Cambridge Affordable Housing Trust Meeting
The Affordable Housing Trust will hold its monthly meeting in-person and via Zoom webinar. October's meeting will be held on October 22, 2026 at 4 p.m. at City Hall, 795 Massachusetts Ave, in the Ackermann Room. Register to join the October 2026 Affordable Housing Trust meeting.
The meeting agenda and meeting materials will be posted on the Affordable Housing Trust webpage.
Cambridge Affordable Housing Trust Meeting
The Affordable Housing Trust will hold its monthly meeting in-person and via Zoom webinar. September's meeting will be held on September 24, 2026 at 4 p.m. at City Hall, 795 Massachusetts Ave, in the Ackermann Room. Register to join the September 2026 Affordable Housing Trust meeting.
The meeting agenda and meeting materials will be posted on the Affordable Housing Trust webpage.
Cambridge Affordable Housing Trust Meeting
The Affordable Housing Trust will hold its monthly meeting in-person and via Zoom webinar. October's meeting will be held on November 19, 2026 at 4 p.m. at City Hall, 795 Massachusetts Ave, in the Ackermann Room. Register to join the November 2026 Affordable Housing Trust meeting.
The meeting agenda and meeting materials will be posted on the Affordable Housing Trust webpage.
Cambridge Affordable Housing Trust Meeting
The Affordable Housing Trust will hold its monthly meeting in-person and via Zoom webinar. October's meeting will be held on December 17, 2026 at 4 p.m. at City Hall, 795 Massachusetts Ave, in the Ackermann Room. Register to join the December 2026 Affordable Housing Trust meeting.
The meeting agenda and meeting materials will be posted on the Affordable Housing Trust webpage.
FDA Issues Emergency Use Authorization for Third COVID-19 Vaccine
The U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the third vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The EUA allows the Janssen COVID-19 Vaccine to be distributed in the U.S for use in individuals 18 years of age and older.